In line with our meta-analysis, previous studies have reported that circulating levels of follistatin are increased in PCOS independent of body mass index [64, 65], suggesting that obesity is not the explanatory factor for the increased levels of follistatin among women with PCOS. Here, FST is linked to obesity due to melanocortin 4 receptor deficiency.